Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Bowzyk Al-Naeeb

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|August 24, 2018
Non-Hodgkin lymphomaAnna Bowzyk Al-Naeeb, Thankamma Ajithkumar, Sarah Behan, et al.
Lancet (London, England)|July 2, 2023
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testingRatna Wijaya, Marina Johnson, Nicola Campbell, et al.
Nature Cancer|March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO studySean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|August 24, 2018
Non-Hodgkin lymphomaAnna Bowzyk Al-Naeeb, Thankamma Ajithkumar, Sarah Behan, et al.
Lancet (London, England)|July 2, 2023
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testingRatna Wijaya, Marina Johnson, Nicola Campbell, et al.
Nature Cancer|March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO studySean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.
Pageof 1